Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs
暂无分享,去创建一个
J. Montastruc | M. Berlan | C. Damase-Michel | G. Tavernier | M. Tran | P. Montastruc | M. Poncet | Paul Montastruc | Michel Berlan
[1] A. Sollevi,et al. Elevation of plasma neuropeptide Y‐like immunoreactivity and noradrenaline during myocardial ischaemia in man , 1990, Journal of internal medicine.
[2] B. Kennedy,et al. Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. , 1990, American journal of hypertension.
[3] A. Franco‐Cereceda,et al. Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)‐mediated sympathetic cotransmission , 1990, Fundamental & clinical pharmacology.
[4] R. Nadeau,et al. Alpha 2-adrenoceptor modulation of catecholamine and neuropeptide Y responses during haemorrhagic hypotension in anaesthetized dogs. , 1990, Journal of the autonomic nervous system.
[5] A. Sollevi,et al. Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. , 1990, Cardiovascular research.
[6] A. Sollevi,et al. Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: Importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport , 1989, Neuroscience.
[7] P. Valet,et al. PLASMA CATECHOLAMINES AND ADRENOCEPTORS AFTER CHRONIC SINOAORTIC DENERVATION IN DOGS , 1989, Fundamental & clinical pharmacology.
[8] P. Valet,et al. Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects , 1989, British journal of pharmacology.
[9] J. Montastruc,et al. Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog. , 1989, The Journal of pharmacology and experimental therapeutics.
[10] L. Kaijser,et al. α‐Adrenoceptor Influence on Plasma Levels of Neuropeptide Y‐Like Immunoreactivity and Catecholamines During Rest and Sympathoadrenal Activation in Humans , 1988, Journal of cardiovascular pharmacology.
[11] P. Hjemdahl. Plasma catecholamines as markers for sympatho-adrenal activity in human primary hypertension. , 1988, Pharmacology & toxicology.
[12] M. Konarska,et al. Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. , 1988, Life sciences.
[13] P. Valet,et al. Nicardipine causes sympathetic activation that does not involve baroreceptor reflex tachycardia in conscious sinoaortic-denervated dogs. , 1987, European Journal of Pharmacology.
[14] V. Castagné,et al. Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines , 1987, Regulatory Peptides.
[15] J. Lundberg,et al. Alpha 2-adrenoceptor-mediated inhibition of nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea-pig. , 1986, European journal of pharmacology.
[16] P. F. Rogers,et al. Plasma Catecholamines and Neuropeptide‐Y as Indices of Sympathetic Nerve Activity in Normotensive and Stroke‐Prone Spontaneously Hypertensive Rats , 1986, Journal of cardiovascular pharmacology.
[17] J. Chalmers,et al. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. , 1986, Journal of the autonomic nervous system.
[18] P. Hjemdahl,et al. Co-release of neuropeptide Y and catecholamines during physical exercise in man. , 1985, Biochemical and biophysical research communications.
[19] S. Bloom,et al. Release of neuropeptide Y in response to splanchnic nerve stimulation in the conscious calf. , 1984, The Journal of physiology.
[20] M. Goldberg,et al. Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor. , 1983, Pharmacological reviews.